Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients
Quoc Truong(West Virginia University), Aaron Cumpston(West Virginia University Hospitals), Lauren Veltri(West Virginia University), Yanqing Hu(Io Therapeutics (United States)), Michael Craig(Edith Cowan University), Abraham S. Kanate(HonorHealth), Mehdi Hamadani(Medical College of Wisconsin)
Cited by 22
Related Papers
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
|Journal of Clinical Oncology|2019|441